Study Stopped
Protocol Under Review
The Role of Ribose in Patients Diagnosed With Fibromyalgia
The Role of D-RIbose in Patients Diagnosed With Fibromyalgia
1 other identifier
interventional
200
1 country
1
Brief Summary
The purose of this research study is to determine the potential benefit of D-ribose, a nutritional supplement (a sugar), versus a placebo (another sugar) in people with fibromyalgia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2006
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2006
CompletedFirst Submitted
Initial submission to the registry
November 29, 2007
CompletedFirst Posted
Study publicly available on registry
December 3, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2008
CompletedMarch 13, 2008
March 1, 2008
2 years
November 29, 2007
March 10, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Significant reduction in symptoms of pain and fatigue
3 weeks
Secondary Outcomes (1)
Demonstrate an improvement in ones quality of life
3 weeks
Study Arms (2)
1
ACTIVE COMPARATORD-ribose 5 grams TID orally
2
PLACEBO COMPARATORDextrose 5 grams TID
Interventions
Eligibility Criteria
You may qualify if:
- previous diagnosis of fibromomyalgia by a MD
- Has been diagnosed with fibromyalgia and are over 18 years of age
- Does live in the United States
You may not qualify if:
- does NOT have severe medication/chemical/supplement sensitivities
- does NOT have insulin dependent diabetes or other severe illnesses (cancer, hepatitis, congestive heart failure)
- does NOT have rheumatoid arthritis or gout
- previous use of ribose
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bioenergy Life Science, Inc.
Minneapolis, Minnesota, 55304, United States
Related Publications (1)
Teitelbaum JE, Johnson C, St Cyr J. The use of D-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study. J Altern Complement Med. 2006 Nov;12(9):857-62. doi: 10.1089/acm.2006.12.857.
PMID: 17109576BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jacob Teitelbaum, MD
The Annapolis Center for Effective CFS/Fibromyalgia Therapies
- PRINCIPAL INVESTIGATOR
Kent Holtorf, MD
Hormone and Longevity Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
November 29, 2007
First Posted
December 3, 2007
Study Start
July 1, 2006
Primary Completion
July 1, 2008
Study Completion
July 1, 2008
Last Updated
March 13, 2008
Record last verified: 2008-03